Similar articles for PMID: 19752137

Year	Number of Results
2001	1
2002	2
2003	11
2004	5
2005	5
2006	6
2007	18
2008	3
2009	13
2010	10
2011	5
2012	2
2013	6
2014	1
2015	1
2016	2
2017	1
2018	5
2019	4
2020	2
2022	1
2024	0

1

Enzyme therapy for Fabry patients in jeopardy.

Silversides A. Silversides A. CMAJ. 2009 Sep 15;181(6-7):E120. doi: 10.1503/cmaj.109-3013. CMAJ. 2009. PMID: 19752137 Free PMC article. No abstract available.

2

Fabry trial set to answer "political problem".

Silversides A. Silversides A. CMAJ. 2009 Sep 15;181(6-7):365-6. doi: 10.1503/cmaj.109-3015. CMAJ. 2009. PMID: 19752140 Free PMC article. No abstract available.

3

Agalsidase alfa: specific treatment for Fabry disease.

Mehta A. Mehta A. Hosp Med. 2002 Jun;63(6):347-50. doi: 10.12968/hosp.2002.63.6.2005. Hosp Med. 2002. PMID: 12096664 Review.

4

Clinical trial for Fabry disease faces continuing hurdles.

Silversides A. Silversides A. CMAJ. 2009 Nov 24;181(11):E251-2. doi: 10.1503/cmaj.109-3071. Epub 2009 Oct 13. CMAJ. 2009. PMID: 19825933 Free PMC article. No abstract available.

5

[Results of enzyme replacement therapy in Fabry disease nephropathy].

Dussol B. Dussol B. Presse Med. 2007 Mar;36 Spec No 1:1S43-7. Presse Med. 2007. PMID: 17546767 Review. French.

6

Modelling the resource implications of managing adults with Fabry disease in Italy.

Guest JF, Concolino D, Di Vito R, Feliciani C, Parini R, Zampetti A. Guest JF, et al. Eur J Clin Invest. 2011 Jul;41(7):710-8. doi: 10.1111/j.1365-2362.2010.02458.x. Epub 2011 Feb 8. Eur J Clin Invest. 2011. PMID: 21299550

7

Enzyme replacement therapy in an adolescent with Fabry disease.

Illsinger S, Luecke T, Langen H, Das AM. Illsinger S, et al. Eur J Pediatr. 2003 Jul;162(7-8):522-523. doi: 10.1007/s00431-003-1222-y. Epub 2003 May 6. Eur J Pediatr. 2003. PMID: 12733069 No abstract available.

8

Modelling the resource implications of managing adults with Fabry disease in Norway favours home infusion.

Guest JF, Jenssen T, Houge G, Aaseboe W, Tøndel C, Svarstad E. Guest JF, et al. Eur J Clin Invest. 2010 Dec;40(12):1104-12. doi: 10.1111/j.1365-2362.2010.02363.x. Epub 2010 Sep 9. Eur J Clin Invest. 2010. PMID: 21070219

9

Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa.

Wendt S, Whybra C, Kampmann C, Teichmann E, Beck M. Wendt S, et al. J Inherit Metab Dis. 2005;28(5):787-8. doi: 10.1007/s10545-005-0018-9. J Inherit Metab Dis. 2005. PMID: 16151910

10

Fabry disease: the need to stratify patient populations to better understand the outcome of enzyme replacement therapy.

Germain DP. Germain DP. Clin Ther. 2007;29 Suppl A:S17-8. doi: 10.1016/s0149-2918(07)80122-6. Clin Ther. 2007. PMID: 17580237 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year